The FINANCIAL -- Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb Foundation on July 20 announced new grants providing technical assistance...

ImClone Systems and Bristol-Myers Squibb Announce Revisions to ERBITUX

by The FINANCIAL

July 20, 2009

The FINANCIAL -- ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY), and Bristol-Myers Squibb Company (NYSE:...

Xeloda in combination with oxaliplatin shown to be effective in early colon cancer

by The FINANCIAL

July 20, 2009

The FINANCIAL -- Roche announced on July 20 results from the international phase III study NO16968 (XELOXA), investigating oral Xeloda in combination...

Human Genome Sciences and GlaxoSmithKline announce positive Phase 3 study results for Benlysta

by The FINANCIAL

July 20, 2009

The FINANCIAL -- Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) on July 20 announced that Benlysta (belimumab, formerly...

FDA Approves Plan B One-Step, a New One-Pill Emergency Contraceptive

by The FINANCIAL

July 13, 2009

The FINANCIAL -- Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced on July 13 that the U.S. Food and Drug Administration (FDA) has...

Bayer presents positive Phase II data with florbetaben

by The FINANCIAL

July 13, 2009

The FINANCIAL -- Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the...

Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)

by The FINANCIAL

July 6, 2009

The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) announced on July 6 it received a fourth approval from the U.S. Food...

Novartis becomes first healthcare company to join United Against Malaria partnership

by The FINANCIAL

July 6, 2009

The FINANCIAL -- On July 6 Novartis announced the delivery of the 250,000,000th treatment of Coartem, a highly-effective artemisinin-based combination therapy (ACT)...

Christian Lajoux appointed President for sanofi-aventis in France

by The FINANCIAL

June 29, 2009

The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on June 29 that Christian Lajoux is appointed President for sanofi-aventis in...

UCB brings Neupro back to all patients in Europe

by The FINANCIAL

June 29, 2009

The FINANCIAL -- UCB announced on June 29 that Neupro (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic...

Takeda Submitted an Application for an Additional Indication of Alogliptin

by The FINANCIAL

June 29, 2009

The FINANCIAL -- Takeda Pharmaceutical Company Limited (Takeda) on June 29 announced that it submitted an application for an additional indication of...

Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets

by The FINANCIAL

June 29, 2009

The FINANCIAL -- Bayer Schering Pharma AG, Germany, has entered into an exclusive license agreement with Celera Corporation, California, USA,...

Merck, Schering-Plough get second FTC request

by The FINANCIAL

June 22, 2009

The FINANCIAL -- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) on June 22 announced that they each have...

GSK announces a strategic alliance with Dr. Reddy’s

by The FINANCIAL

June 15, 2009

The FINANCIAL -- GlaxoSmithKline plc (GSK) on June 15 announced an agreement with Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) to develop and...

UCB and PatientsLikeMe partner to give people with epilepsy a voice in advancing research

by The FINANCIAL

June 15, 2009

The FINANCIAL -- Biopharma company UCB and PatientsLikeMe, the leading online community for people with life-changing conditions, on June 15 announced a...